~~<i id='FD5577D45F'><strike id='FD5577D45F'><tt id='FD5577D45F'><pre id='FD5577D45F'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：hotspot 2025-10-01 03:40:38 Page View：3

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： A new nitrogen execution bill also undermines medical licensing
Next article： Drug repurposing or repositioning? The language matters

explore

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Radiation, mainstay of cancer treatment, begins a fade

Amaskusedinradiationtherapyshowslaserlinesfortargetingcancercellsinthebrain.AdobeEveryyear,doctorsge

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

2024 GOP presidential candidates spar over abortion in debate

APPhoto/MorryGashWASHINGTON—RepublicanpresidentialcandidatessparredWednesdayoveraquestionthathashaun